OV-6 Antibody (OV-6) [PE/Cy7]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2020PECY7
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Rat
Applications
Flow Cytometry
Label
PE/Cy7 (Excitation = 488 nm, Emission = 778 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OV-6
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Carcinogen-treated rat nodular hepatocytes
Specificity
Detects human and rat OV-6 antigen.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for OV-6 Antibody (OV-6) [PE/Cy7]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined. For optimal results using our Tandem dyes, please avoid prolonged exposure to light or extreme temperature fluctuations. These can lead to irreversible degradation or decoupling. When staining intracellular targets, specific attention to the fixation and permeabilization steps in your flow protocol may be required. Please contact our technical support team at technical@novusbio.com if you have any questions.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark. Do not freeze.
Background: OV-6
Long Name
Oval Cell Marker
Alternate Names
OV6
Additional OV-6 Products
Product Documents for OV-6 Antibody (OV-6) [PE/Cy7]
Product Specific Notices for OV-6 Antibody (OV-6) [PE/Cy7]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...